2022

In early March 2022, the United States Food and Drug Administration (FDA) finalized guidance to help regulated industries (i.e.,…

Eosinophilic esophagitis (EoE) has become a major cause of upper gastrointestinal morbidity with significant impacts on patient…

Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic infectious condition most frequently caused by Mycobacterium…

On March 15, 2022, a study led by researchers at Johns Hopkins Bloomberg School of Public Health was published in the Annals of…

On April 5, 2022, the Physicians Foundation released Part One of Three: 2022 Survey of America’s Physicians, which examined the…

Earlier this year, Kentucky lawmakers introduced House Bill 457, focused on curtailing the powers of pharmacy benefit managers…

On April 4, 2022, the United States Department of Justice announced that it filed a complaint against several individuals and…

On April 21, 2022, the United States Food and Drug Administration (FDA) filed a Notice and Request for Comment regarding a…

Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…

The DOL, HHS, and IRS issued a report to Congress on the failure by group health plans to comply with the Mental Health Parity and…